Q: First bought a small position when it had dropped to $90 from its alt-time of around $117. Averaged down several months ago to a $53 cost and about a 3.5% position. Am thinking about chasing it at its current price of $29 to lower my cost to $40. Can't understand the downward pressure on this stock. I know it has some debt but also strong earnings. Can't help but think of Teck when it was down below $4 not that long ago and now is over $15. I don't like averaging down but it just seems so mis-priced. Forgetting about the short manipulations, do you you see any faundamental downside risk.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I purchased ATD.A (multiple voting shares) not realizing there are differing options. As a retail investor, is there an advantage to purchasing the class A vs. class B?
Q: Hello team,
thank you for your all your investments answers and for the ones regarding Concordia Healthcare in particular.
Going forward it seems that unfortunately the sentiment towards Biotech stocks, Brexit, the similarities with Valeant, short attacks and other possible concerns with CXR is simply killing the share price and CXR has become a falling knife...
In addition technically speaking it just broke below 2016 lows... Do you still think its buyable now?
Thx again!
thank you for your all your investments answers and for the ones regarding Concordia Healthcare in particular.
Going forward it seems that unfortunately the sentiment towards Biotech stocks, Brexit, the similarities with Valeant, short attacks and other possible concerns with CXR is simply killing the share price and CXR has become a falling knife...
In addition technically speaking it just broke below 2016 lows... Do you still think its buyable now?
Thx again!
Q: I find your answer to the question on couche tard being down the last 2 weeks off the mark.
If they make another purchase and have to do a fund raise would not that be a good thing-- accreditive to earnings, cut costs etc etc, is not that the way couche tard became so successful in the first place.
What am i missing. Dave
If they make another purchase and have to do a fund raise would not that be a good thing-- accreditive to earnings, cut costs etc etc, is not that the way couche tard became so successful in the first place.
What am i missing. Dave
Q: What is happening with Couche-Tard. Seems to be losing value continually...
Q: Hello, I am wondering where you guys can put the floor price for that stock (where is become so cheap that big investors will buy the stock) considering the fact that it seems that there is no institutional appetite for that stock even if it is falling like a rock and become cheaper...
The apparent "cheap" valuation of the company at this point does not seem to attract any big players and even if I believe in the company's potential.
I am scratching my head due to the fact that there is actually mostly short sellers attracted to the stock and as the share price keep falling, the company seems less and less it seems to me that the company lost control of its own destiny.
The apparent "cheap" valuation of the company at this point does not seem to attract any big players and even if I believe in the company's potential.
I am scratching my head due to the fact that there is actually mostly short sellers attracted to the stock and as the share price keep falling, the company seems less and less it seems to me that the company lost control of its own destiny.
Q: What would be your current number 1 picks (1-2 year total return) for a dividend paying stock and for a non dividend stock - regardless of industry? Thanks!
Q: Do you think that Enghouse has had it's run? Is it time to sell and replace it with SIS? Thank You.
Q: Does theBriexit vote have any impact on the outcome relating to "it" and or other gaming stocks.
Q: Hi , if Britain leaves , will the "market" perceive it as a negative to ATD.B
- would it make more sense to sit on the sidelines for June , or maybe scale in on dips
Thanks,
David
- would it make more sense to sit on the sidelines for June , or maybe scale in on dips
Thanks,
David
Q: Hello 5i team,
I'm currently building a portfolio from scratch for my mother who is 61 and retired. We are thinging conservative value and income equities for 10+ years.
Which 5 stocks, either from your balanced or income portfolio would you use as building blocks? If possible, can you recommend stocks that are fairly priced at the moment?
Thank you for your excellent service,
Cam.
I'm currently building a portfolio from scratch for my mother who is 61 and retired. We are thinging conservative value and income equities for 10+ years.
Which 5 stocks, either from your balanced or income portfolio would you use as building blocks? If possible, can you recommend stocks that are fairly priced at the moment?
Thank you for your excellent service,
Cam.
Q: Hello Peter and team, Your assessment please on ET's earnings yesterday. Still consider it basically as income more than growth?
Thank you!
Silvia
Thank you!
Silvia
Q: I'm interested in PUR as an investment & would appreciate your comments on its future.I realize they had a strong last quarter.Currently I have 5% holdings of both SIS & DBO & they are doing well for me.If you like it, what %age of PUR should I buy or am I getting too much money in small caps.What %age of small caps would you recommend ? Thanks as always.
Q: Hello 5i team,
I am currently up 48% on CXI and am contemplating switching to Savaria (SIS). This would be within my TFSA. I am overweight financials (as most Canadians probably are..) and currently underweight industrials.
Would you endorse such a move; are there any "red flags" you would see to such a switch? Any thoughts or comments would be much appreciated.
Cheers,
Mike
I am currently up 48% on CXI and am contemplating switching to Savaria (SIS). This would be within my TFSA. I am overweight financials (as most Canadians probably are..) and currently underweight industrials.
Would you endorse such a move; are there any "red flags" you would see to such a switch? Any thoughts or comments would be much appreciated.
Cheers,
Mike
Q: Is this a good entry point for Alimentation Couche Tard? Thank you
Q: I want to increase my equity allocation ; it is still correct to simply buy your whole balanced equity portfolio (5 % each names) ?
Q: It's being reported that Apollo Global Mgmt has submitted a bid for CXR. Will the company release details of the bid, and if so, how soon?
Q: you seem to get a question on couche tard everytime it declines, and i know it is one of your favorites.
so is the recent decline due to sector rotation, cdn dollar strength, margins on gas etc or what.
i would think with the recent purchse of esso stations in mtl, possible bidding on valero and loblaws stations the stock would be rising, also most targets are in the 70 dollar range. dave
so is the recent decline due to sector rotation, cdn dollar strength, margins on gas etc or what.
i would think with the recent purchse of esso stations in mtl, possible bidding on valero and loblaws stations the stock would be rising, also most targets are in the 70 dollar range. dave
Q: I hold these 3 plus XLV in the health care portion of my portfolio. Not adverse to risk but I am wondering whether CXR is worth the grief. Is there a case for focussing on the others, or does the risk/reward of CXR make it worthwhile holding?
Q: Hi Peter!
If the Growth portfolio had to be reduced to 10 names what would be your top pick today?
correction... on this question it should read top 10 picks today not top pick. Thank you!
Ian
If the Growth portfolio had to be reduced to 10 names what would be your top pick today?
correction... on this question it should read top 10 picks today not top pick. Thank you!
Ian